COMORBIDITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THYROID DYSFUNCTION
https://doi.org/10.52485/19986173_2024_4_117
Abstract
Chronic obstructive pulmonary disease (COPD) and endocrinological conditions, such as thyroid dysfunction, are both associated with chronic inflammation. Epidemiological studies have shown that patients with COPD have a higher risk for developing thyroid dysfunction compared to the general population. This comorbidity has not been well studied, and its diagnosis can be difficult due to the combined burden and layering of clinical symptoms, while this combination of the disease can seriously worsen the quality of life of patients. Understanding the relationship between thyroid dysfunction and COPD can help improve the clinical prognosis in these patients. The review examines the existing links between COPD and thyroid diseases, their mechanisms and clinical features.
About the Authors
A. V. Pashkevich
Chita State Medical Academy
Russian Federation
Russian Federation
Pashkevich A.V., assistant of the Department of Hospital Therapy
AuthorID: 1268578
39а Gorky St., Chita, Russia, 672000
O. V. Serebryakova
Chita State Medical Academy
Russian Federation
Russian Federation
Serebryakova O.V., Doctor of medical sciences, Professor, Head of the Department of Hospital Therapy
AuthorID: 433959
39а Gorky St., Chita, Russia, 672000
References
1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2023 https://goldcopd.org
2. Papaioannou O., Karampitsakos T., Barbayianni I., et al. Metabolic Disorders in Chronic Lung Diseases. Front Med (Lausanne). 2018 Jan 18. 4.246. doi: 10.3389/fmed.2017.00246.
3. García-Olmos L., Alberquilla A., Ayala V., et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross-sectional study. BMC Fam Pract. 2013 Jan 16. 14.11. doi: 10.1186/1471-2296-14-11.
4. Miłkowska-Dymanowska J., Białas A.J., Laskowska P., et al. Thyroid gland in chronic obstructive pulmonary disease. Adv Respir Med. 2017.85 (1). 28–34. doi: 10.5603/ARM.2017.0006.
5. Korytina G., Akhmadishina L., Kochetova O., et al. Inflammatory and Immune Response Genes Polymorphisms are Associated with Susceptibility to Chronic Obstructive Pulmonary Disease in Tatars Population from Russia. Biochem Genet. 2016 Aug.54(4).388-412. doi: 10.1007/s10528-016-9726-0.
6. Stouthard J., Van der Poll T., Endert E., et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab. 1994 Nov. 79 (5).1342-6. doi: 10.1210/jcem.79.5.7962327.
7. Karadag F., Ozcan H., Karul AB., Yilmaz M., Cildag O. Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease. Respir Med. 2007 Jul.101(7).1439-46. doi: 10.1016/j.rmed.2007.01.016.
8. McCusker K. Mechanisms of respiratory tissue injury from cigarette smoking. Am J Med. 1992 Jul 15.93(1A).18-21. doi: 10.1016/0002-9343(92)90622-i.
9. Meral I., Arslan A., Him A., Arslan H. Smoking-related Alterations in Serum Levels of Thyroid Hormones and Insulin in Female and Male Students. Altern Ther Health Med. 2015 Sep-Oct. 21 (5). 24–9. PMID: 26393988.
10. Laghi F., Adiguzel N., Tobin M. Endocrinological derangements in COPD. Eur Respir J. 2009 Oct. 34 (4). 975-96. doi: 10.1183/09031936.00103708.
11. Gow S., Seth J., Beckett G., Douglas G. Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease. Thorax. 1987 Jul. 42 (7). 520-5. doi: 10.1136/thx.42.7.520.
12. Chaudhary S., Ahmad T., Usman K., et al. Prevalence of thyroid dysfunction in chronic obstructive pulmonary disease patients in a tertiary care center in North India. J Family Med Prim Care. 2018 May- Jun. 7 (3). 584–588. doi: 10.4103/jfmpc.jfmpc_84_17.
13. Sarinc Ulasli S., Bozbas S., Ozen Z., Ozyurek B., Ulubay G. Effect of thyroid function on COPD exacerbation frequency: a preliminary study. Multidiscip Respir Med. 2013 Oct 1. 8(1). 64. doi: 10.1186/2049-6958-8- 64.
14. Terzano C., Romani S., Paone G., Conti V., Oriolo F. COPD and thyroid dysfunctions. Lung. 2014 Feb.192(1).103-9. doi: 10.1007/s00408-013-9537-6.
15. Dimopoulou I., Ilias I., Mastorakos G., et al. Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism. 2001 Dec. 50 (12). 1397-401. doi: 10.1053/meta.2001.28157.
16. Bacakoğlu F., Başoğlu O., Gürgün A., et al. Can impairments of thyroid function test affect prognosis in patients with respiratory failure? Tuberk Toraks. 2007.55(4).329-35
17. Miłkowska-Dymanowska J., Białas A., Laskowska P., Górski P., Piotrowski W. Thyroid gland in chronic obstructive pulmonary disease. Adv Respir Med. 2017. 85 (1). 28–34. doi: 10.5603/ARM.2017.0006.
18. Lee S., Pearce E. Hyperthyroidism: A Review. JAMA. 2023 Oct 17.330(15).1472-1483. doi: 10.1001/jama.2023.19052.
19. Agin K., Namavary J. A Survey on Thyroid Hormonal Status among Moderate to Severe Stable Chronic Obstructive Pulmonary Disease. International Journal of Medical Toxicology and Forensic Medicine. 2012. (3). 106–113. https://doi.org/10.22037/ijmtfm.v3i4(Autumn).3643
20. Siafakas N., Salesiotou V., Filaditaki V., et al. Respiratory muscle strength in hypothyroidism. Chest. 1992 Jul. 102 (1). 189–94. doi: 10.1378/chest.102.1.189.
21. Pino-García J., García-Río F., Díez J., et al. Regulation of breathing in hyperthyroidism: relationship to hormonal and metabolic changes. Eur Respir J. 1998Aug.12(2).400-7. doi: 10.1183/09031936.98.12020400.
22. Siafakas N., Milona I., Salesiotou V., et al. Respiratory muscle strength in hyperthyroidism before and after treatment. Am Rev Respir Dis. 1992 Oct.146(4).1025-9. doi: 10.1164/ajrccm/146.4.1025.
23. Luo Y., Zhou L., Li Y, Guo S., et al. Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD. Respir Care. 2016 May.61(5).680-8. doi: 10.4187/respcare.04358.
24. Uzun K., Atalay H., Inal A. Thyroid hormon levels in patients with acute exacerbation of chronic obstructive pulmonary disease. Eur J Gen Med. 2007.4. 80–82.
25. El-Yazed H., El-Bassiony M., Eldaboosy S., et al. Assessment of thyroid functions in patients with chronic obstructive pulmonary disease. Egyptian Journal of Chest Diseases and Tuberculosis. 2013. 62(3). 387– 391. doi: 10.1016/j.ejcdt.2013.07.009
26. Akpınar E. An underestimated comorbidity of COPD: Thyroid dysfunction. Tuberk Toraks. 2019 Jun. 67 (2). 131–135. doi: 10.5578/tt.68257.
27. Yasar Z., Kirakli C., Cimen P., et al. Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients? Int J Clin Exp Med. 2015 Jun 15.8(6).10114-21.
28. Mancini A., Corbo G., Gaballo A, et al. Relationship between plasma antioxidants and thyroid hormones in chronic obstructive pulmonary disease. Exp Clin Endocrinol Diabetes. 2012 Nov.120(10).623-8. doi: 10.1055/s-0032-1323808.
Review
For citations:
Pashkevich A.V., Serebryakova O.V. COMORBIDITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THYROID DYSFUNCTION. Transbaikalian Medical Bulletin. 2024;(4):117-125. (In Russ.) https://doi.org/10.52485/19986173_2024_4_117
Views:
121
Email this article 